Literature DB >> 17969113

Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy.

Andrew M Blamire1, Sarah Cader, Martin Lee, Jackie Palace, Paul M Matthews.   

Abstract

Axonal damage is a major factor contributing to permanent disability in patients with multiple sclerosis (MS); it has been extensively investigated in the brain using magnetic resonance spectroscopy (MRS). In this study, MRS was used to investigate the degree of neuronal damage in the cervical spinal cord in MS. Spectra were acquired from spinal cord and brain in 11 patients with MS (expanded disability status score [EDSS], range 2.5-7.0) and 11 controls. Brain lesion volume and spinal cord cross-sectional area were measured. Concentration of the neuronal metabolite N-acetyl-aspartate ([NAA]) was reduced in the spinal cord in MS patients relative to controls (reduced by 32%, P < 0.05), indicating significant neuronal damage. Additionally, the spinal cord was significantly atrophied in MS patients (15%, P < 0.001). No significant reduction in brain [NAA] was seen in the MS group. There were no correlations between clinical measures and cord atrophy or brain lesion volume on MRI; however, spinal cord [NAA] correlated with the cerebellar subscore of the neurological assessment (P < 0.005), while brain [NAA] correlated with disease duration (P < 0.05). MRS demonstrated cellular damage within the cord over and above the tissue atrophy seen by MRI. Combining MRI and MRS may therefore give a more complete picture of neurodegeneration in the spinal cord. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17969113     DOI: 10.1002/mrm.21382

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  20 in total

Review 1.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

Review 2.  (1)H-MR spectroscopy in the human spinal cord.

Authors:  A Hock; A Henning; P Boesiger; S S Kollias
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-13       Impact factor: 3.825

Review 3.  Application of magnetic resonance imaging in cervical spondylotic myelopathy.

Authors:  Chuan Zhang; Sushant K Das; Dong-Jun Yang; Han-Feng Yang
Journal:  World J Radiol       Date:  2014-10-28

4.  1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis.

Authors:  Barbara Bellenberg; Martin Busch; Nadine Trampe; Ralf Gold; Andrew Chan; Carsten Lukas
Journal:  Eur Radiol       Date:  2013-07-25       Impact factor: 5.315

5.  Metabolic Imaging Using Proton Magnetic Spectroscopy as a Predictor of Outcome After Surgery for Cervical Spondylotic Myelopathy.

Authors:  Langston T Holly; Benjamin M Ellingson; Noriko Salamon
Journal:  Clin Spine Surg       Date:  2017-06       Impact factor: 1.876

6.  Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.

Authors:  Khaled Abdel-Aziz; Torben Schneider; Bhavana S Solanky; Marios C Yiannakas; Dan R Altmann; Claudia A M Wheeler-Kingshott; Amy L Peters; Brian L Day; Alan J Thompson; Olga Ciccarelli
Journal:  Brain       Date:  2015-04-10       Impact factor: 13.501

Review 7.  Progressive multiple sclerosis and gray matter pathology: an MRI perspective.

Authors:  Matilde Inglese; Niels Oesingmann; Patrizia Casaccia; Lazar Fleysher
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

8.  Neuronal and axonal degeneration in experimental spinal cord injury: in vivo proton magnetic resonance spectroscopy and histology.

Authors:  Junchao Qian; Juan J Herrera; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

9.  Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.

Authors:  Kathleen M Zackowski; Seth A Smith; Daniel S Reich; Eliza Gordon-Lipkin; BettyAnn A Chodkowski; Divya R Sambandan; Michael Shteyman; Amy J Bastian; Peter C van Zijl; Peter A Calabresi
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

Review 10.  Advances in MR imaging for cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Langston T Holly
Journal:  Eur Spine J       Date:  2013-08-06       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.